Lipid Nucleoside Conjugates for the Treatment of Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|9|1079-1089

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.9, 2005-04, pp. : 1079-1089

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oligonucleotides and Oligonucleotide Conjugates: A New Approach for Cancer Treatment

By  

Current Medicinal Chemistry, Vol. 12, Iss. 1, 2005-01 ,pp. : 71-88

Bentham Science Publishers

Access to resources Recommend Favorite

Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment

By Gormley Adam J.   Malugin Alexander   Ray Abhijit   Robinson Ryan   Ghandehari Hamidreza  

Journal of Drug Targeting, Vol. 19, Iss. 10, 2011-12 ,pp. : 915-924

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Antibody-Drug Conjugates for Breast Cancer Treatment

By  

Current Medicinal Chemistry, Vol. 24, Iss. 23, 2017-09 ,pp. : 2505-2527

Bentham Science Publishers

Access to resources Recommend Favorite

Nucleoside and nucleobase analogs in cancer treatment: not only sapacitabine, but also gemcitabine

By Muggia Franco   Diaz Isabela   Peters Godefridus J  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 4, 2012-04 ,pp. : 403-408

Informa Healthcare

Access to resources Recommend Favorite

Lipid-Based Drug Delivery Systems for Cancer Treatment

By  

Current Drug Targets, Vol. 12, Iss. 8, 2011-07 ,pp. : 1151-1165

Bentham Science Publishers

Access to resources Recommend Favorite